Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in number of shares and votes in Ascelia Pharma AB

During July 2020, the number of shares and votes in Ascelia Pharma AB increased due to the directed new share issue, which was completed on 30 June 2020. Per 31 July 2020, the number of shares amounts 28,697,234, whereof 28,186,689 are ordinary shares with one vote per share and 510,545 are class C shares with one-tenth of a vote per share. The total number of votes in the company amounts to 28,237,743.5. For further information, please contact:Magnus Corfitzen, CEOEmail: moc@ascelia.comTel: +46 735 179 118Mikael Widell, Head of IR & CommunicationsEmail: mw@ascelia.com 

First patient treated in Stayble’s clinical phase 2b study

Stayble Therapeutics announces today, July 31, 2020, that the first patient has been treated in Stayble’s clinical phase 2b study. STA363 is targeting patients suffering from chronic low back pain caused by disc degeneration.The primary goal of the phase 2b trial is to demonstrate safety, tolerability and a clinically relevant reduction in pain in patients. The study will include some 100 patients and will be conducted at about 20 clinical sites in the Netherlands, Russia and Spain. Patients will be treated with either a high or low dose of STA363 or placebo. The longest patient follow-up

Fellow Finance CFO Niko Stark on a medical leave

FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 31.7.2020 AT 14:30 PMFellow Finance company CFO Niko Stark will be taking a long-term leave of absence from the Company in order to undergo treatment for severe medical condition from 31 July 2020 onwards. The duration of the leave is yet unknown. For the present Mr. Stark’s duties will be carried out by Financial Administration Controller Markus Laitinen working in the Financial Department of the company. Further enquiries Teemu Nyholm, Interim-CEO, Fellow Finance Plc, +358 50 577 1028 Evli Bank Plc, Certified Advisor, Evli Bank Plc +358

New number of shares and votes in AB Volvo

The number of shares and votes in AB Volvo has changed due to the conversion of a total of 835 686 Series A shares to a total of 835 686 Series B shares and due to the reduction of the share capital by way of cancellation of the company’s own 20,728,135 Series A shares and 74,420,001 series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting. The cancellation of shares has been implemented in

Interim report 1 January – 30 June 2020

Second quarter 2020 – Bergs reports improved result and strong cash flowDespite the ongoing Covid-19 pandemic, demand for Bergs’s products has been good. The market for wood products has strengthened during the second quarter and prices for wood products have been gradually raised. The market for do-it-yourself, renovation and garden products has developed strongly, while a decline in industrial construction in Europe and the USA has been noted. Bergs focus on the garden range and the do-it-yourself segment has been favorable and sales volumes, mainly in May and June, have been strong.

Change in the number of shares and votes in Starbreeze

STOCKHOLM, SWEDEN (31 July 2020) – Starbreeze AB today announces that the number of Class B shares increased by 715,333 and the number of Class A shares decreased by the same number during July due to the company’s ongoing conversion program. The number of votes decreased by 6,437,997.    In accordance with the articles of association Class A shares shall, upon request of the holder of such shares, be converted into Class B shares. In July 715,333 Class A shares were converted into Class B shares, which did not change the total number of shares but reduced the number of votes. As of

Number of shares and votes in Calliditas Therapeutics

During July, Calliditas Therapeutics AB (publ) has issued 706,676 common shares as a result of the exercise of the over-allotment option within the initial public offering on The Nasdaq Global Select Market and the concurrent private placement of common shares to certain qualified investors in Europe and certain other jurisdictions outside of the United States. Further, during July, warrants within the company’s warrant program issued in 2017 have been converted to 1,185,250 common shares. Thus, as of July 31, 2020, the number of shares and votes in the company amounts to 49,830,334. For

Bulletin from the Extraordinary General Meeting in Brighter AB (publ) on July 31 2020

At the Extraordinary General Meeting in Brighter AB (publ) on Friday July 31 2020, the following main resolutions were adopted. For detailed information about the resolutions we kindly refer to the notice of the Extraordinary General Meeting as well as the proposals which are available on the company’s website, www.brighter.se.  The General Meeting resolved that the Board shall consist of five directors elected by the meeting. The General Meeting resolved that Emilie Erhardt Winiarski, Hab El Assaad, Sofia Landström, Åsa Sjöblom Nordgren and Truls Sjöstedt shall be elected as

July 2020: Ingka Group news

· IKEA introduces plant ball · IKEA Pulse Report #2: Redefining a better Life at Home · IKEA Australia creates flatpack ‘Mindsets’ · New IKEA format stores launched in Germany, Russia, China · IKEA Tmall Flagship Store pilot period extended · IKEA Catalogue 2021 is here · COVID-19: Ingka Group supports 600,000 people IKEA has taken the sustainability journey to the next level by challenging an icon – the meatball - and has created a more sustainable option for the many meatball lovers. IKEA has worked hard to recreate this well known classic product to be a more

Read original

Zalaris UK & Ireland and SpinifexIT Solutions enter a partnership to ease the transition from On Premise SAP to SAP ECP

Zalaris UK & Ireland, a leading SAP implementation and support partner, have today announced a partnership with SpinifexIT, a software solutions provider for SAP HCM and SAP SuccessFactors, to provide a quick and easy way to help businesses transition from their on-premise SAP software to SAP Employee Central Payroll (ECP).Adding SpinifexIT’s Easy Migration solution to their bill of material, Zalaris will be able to accelerate the migration process to SAP ECP through allowing customers to lift and shift their existing Payroll configuration into a new system with ease.With intuitive

Change in number of shares and votes

The second opportunity to convert debentures into shares under the staff convertible debenture programme decided by the Annual General Meeting 2017 was completed in July 2020. Through the conversion, the numbers of B-shares and votes have increased by 9 174. Before the conversion: After the conversion:A-shares: 4 290 336 A-shares: 4 290 336B-shares: 108 160 599 B-shares: 108 169 773Total shares: 112 450 935 Total shares: 112 460 109Total votes: 151 063 959 Total votes: 151 073 133  Corporate CommunicationÅF Pöyry AB (publ)

Major shareholder announcement – BlackRock, Inc.

Vestas Wind Systems A/S, Aarhus, 31 July 2020Company announcement No. 24/2020   Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Danish Capital Market Act. it is hereby announced that BlackRock, Inc., Wilmington, DE, USA, holds 10,054,126 of Vestas shares which corresponds to 5.11 percent of the total share capital in Vestas Wind Systems A/S.  Contact detailsVestas Wind Systems A/S, DenmarkPatrik Setterberg, Vice President,Investor RelationsTel: +45 6122 1913

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During July 2020 14,050 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 597,069,548. The total number of registered shares in the company amounts to 419,903,072, of which 19,685,164 are Series A shares, and 400,217,908 are Series B shares.

Scania Interim Report January-June 2020

The period was strongly dominated by the coronavirus outbreak and its consequences in the form of lower demand and decreased production.Summary of the first six months of 2020 · Net sales decreased by 24 percent to SEK 58,469 m. (77,271) · Operating income decreased by 70 percent to SEK 2,813 m. (9,444) · Cash flow amounted to SEK 1,867 m. (3,638) in Vehicles and Services · In the second quarter of 2020, net sales fell by 38 percent to SEK 25,418 m. (41,179) and operating income decreased to SEK -192 m. (5,237) Comments by Henrik Henriksson, President and CEO “The

A new proposal for the Chairman of the Board will be presented later

On July 30, Brighter announced that the proposed Chairman of the Board, Håkan Nyberg, had chosen to resign from the nomination for personal reasons. The Nomination Committee has since worked hard to be able to present a new candidate for the Extraordinary General Meeting today, 31 July at 10.00. There is a candidate with mutual interest - but further discussions and formalities remain before the candidate can be presented. “We hoped to finish all the formalities before today's meeting, but unfortunately the few hours have not been enough. We would rather work slowly and correctly instead

Ulrika Romantschuk, EVP, Communications & Branding, leaves Fazer

Ulrika Romantschuk, EVP, Communications & Branding and member of the Fazer Group Management Team has informed that she will leave Fazer to take up the position as Head of Brand, Communications and Marketing of Nordea and member of the group leadership team. Ulrika Romantschuk joined Fazer in 2003 and she will continue in her position until October 2020. “Fazer’s good reputation and strong brand are important assets in executing the Group’s growth strategy. I would like to take the opportunity to thank Ulrika for her long contribution to Fazer. I wish her the best of success in her new

Changed number of votes

The number of votes in Vitec Software Group AB (publ.) has in July changed as a result of a conversion of 300,000 Class A shares to 300,000 Class B shares. The conversion has taken place with support of the possibility for A shareholders to request the conversion of A shares into B shares specified in the Articles of Association §5 Class of shares. After the conversion, there are a total of 32,573,216 registered shares, of which 3,050,000 Class A shares with 30,500,000 votes and 29,523,216 Class B shares with 29,523,216 votes. The total number of votes in the company as of July 31, 2020

Nordea appoints Ulrika Romantschuk as Head of Brand, Communications and Marketing

Nordea Bank Abp – Stock exchange release – Changes board/management/auditors Ulrika Romantschuk will join Nordea as Head of Brand, Communications and Marketing. She will also become a member of the Group Leadership Team.  Ulrika Romantschuk, 54, currently serves as Executive Vice President, Communications and Branding, of Fazer Group and has been a member of the Group Management Team since 2005. She also has experience in the financial services sector as Director and Head of Communications of Aktia Bank Plc and Information Officer of Nordic Investment Bank. Ulrika holds a Bachelor

Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy in the first cohort of patients with chemo-resistant metastatic colorectal cancer

Scandion Oncology A/S (“Scandion Oncology”) reports on data from the first cohort of chemotherapy resistant colorectal cancer patients treated with SCO-101 and chemotherapy (FOLFIRI). All patients in the first cohort have now completed at least one treatment cycle (14 days). The main result is that 150 mg daily oral SCO-101 potentiates the effects of chemotherapy (FOLFIRI). Based on the safety data from this first cohort of patients, the Data Safety Monitoring Board has recommended to include 3 additional patients at 150 mg SCO-101 in order to get more details on the interactions between SCO-

New number of shares and votes in Cantargia

The number of shares and votes in Cantargia AB (publ) has changed due to the company's Chairman of the Board, Magnus Persson, exercising his right to subscribe for shares in accordance with the 2017/2020 warrant program. Through the exercise of the warrants, the number of shares and votes in Cantargia increased by 86,700. Today, on the last trading day of the month, there are in total 91,092,189 shares and votes in Cantargia.  For further information, please contactGöran Forsberg, CEOTelephone: +46 (0)46-275 62 60E-mail: goran.forsberg@cantargia.com This information is

Change in number of shares and votes in Evolution Gaming Group AB (publ)

In accordance with the decision at the Annual General Meeting on 17 June 2020, a total of 338,000 shares, which were repurchased between 16 and 17 March 2020 have been cancelled.As of 31 July 2020, following the cancellation, the number of shares and votes in Evolution Gaming Group AB amounts to 181,284,725.   For investor enquiries, please contact:Jacob Kaplan, CFO, ir@evolutiongaming.com This information is such that Evolution Gaming Group AB (publ) is obliged to publish according to the Swedish Financial Instruments Trading Act. The information was published under the auspices

Positive operating income in challenging times

SECOND QUARTER 2020 · Order intake decreased 3% to 62.3 (64.1) MSEK (-4% in constant currencies) · Order backlog amounted to 282.1 (214.5) MSEK · Revenue decreased 17% to 42.9 (51.5) MSEK (-18% in constant currencies) · Operating profit amounted to 0.9 (-0.6) MSEK, corresponding to a margin of 2.1 (-1.2) % · Net results after tax amounted -2.4 (-0.9) MSEK · Result per share amounted to -0.07 (-0.03) SEK JANUARY – JUNE 2020      · Order intake decreased 2% to 110.0 (111.9) MSEK (-3% in constant currencies) · Revenue decreased 4% to 94.7 (98.8) MSEK (-6% in

NextCell Pharma AB publishes its interim report for September 2019 - May 2020

NextCell Pharma AB (publ) (NXTCL) today announces that its Interim report for the period September 1, 2019 - May 31, 2020 now is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-reportNine months (2019-09-01 until 2020-05-31) · Operating income amounted to SEK 3 191 314 (1 273 201). · Operating result amounted to SEK -12 803 349 (-13 477 202). · Earnings per share* amounted to SEK -1,11 (-1,17). · Cash and bank amounted to SEK 5 612 952 (2 249 092). In addition, after the end of the period, in June 2020, the Company received an

There are no items matching the current filter
There are no more items matching the current filter
Back to top